31 studies found for:
" February 15, 2012":" March 16, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Not yet recruiting |
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
|
||||
| 2 | Completed |
Fetal HIV Transmission Risk and Duration of Membrane Rupture
|
||||
| 3 | Recruiting |
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
|
||||
| 4 | Recruiting |
Medical Marijuana Use in HIV+ Patients: Probability Survey
|
||||
| 5 | Recruiting |
Medical Marijuana Use in HIV+ Patients Prospective Cohort Study
|
||||
| 6 | Recruiting |
Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women
|
||||
| 7 | Recruiting |
Assessing the Safety of Dapivirine Gel and Film Formulations
|
||||
| 8 | Recruiting |
Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs
|
||||
| 9 | Recruiting |
Mild Neurocognitive Disorder in HIV Infection of the Brain
|
||||
| 10 | Active, not recruiting |
Phase I/IIa Dose-escalation Clinical Study of VAC-3S
|
||||
| 11 | Unknown † |
Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
|
||||
| 12 | Not yet recruiting |
A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes
|
||||
| 13 | Completed |
Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
|
||||
| 14 | Completed |
Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
|
||||
| 15 | Not yet recruiting |
Testing and Linkage to Care for Injecting Drug Users in Kenya
|
||||
| 16 | Completed |
Sevelamer for Reducing Endotoxemia and Immune Activation
|
||||
| 17 | Recruiting |
Improving Blood Safety and HIV Testing in Brazil
|
||||
| 18 | Available |
Dolutegravir Expanded Access Study
|
||||
| 19 | Recruiting |
Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men
|
||||
| 20 | Recruiting |
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
|
† Indicates status has not been verified in more than two years
